Galderma's Diversified Dermatology Portfolio and Drug Pipeline Position It Well for Long-Term Growth

Galderma is a pure-play dermatology company, with a leadership position in the self-care segment of the market, with more than 90% of total sales paid by consumers out of pocket. Its long-term revenue growth is supported by changing consumer behavior and perception around skin health and appearance. The firm deploys an omnichannel go-to-market strategy, supported by a specialized, high-touch salesforce of over 1,900 employees reaching more than 200,000 healthcare professionals. A leading presence at dermatology congresses complements this, and an emphasis on educational, training, and loyalty programs helps to reinforce physician entrenchment.